Florida Nurse Practitioner Barred from Handling Controlled Substances Over Exclusion
Published Date: 1/15/2026
Notice
Summary
Honorata Anna Itaman, a nurse practitioner from Florida, tried to get a DEA registration but was denied because she’s excluded from Medicare and other federal health programs. She didn’t ask for a hearing, so the denial stands. This means she can’t legally handle controlled substances, affecting her work and income starting now.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
DEA Registration Denied for Itaman
The Drug Enforcement Administration denied Honorata Anna Itaman's application for a DEA Certificate of Registration (Control No. W24026383M). The Order is effective February 17, 2026, and the denial means she cannot hold a DEA registration and therefore cannot legally possess or handle controlled substances, which affects her ability to work and earn income.
Exclusion Blocks DEA Registration
The DEA may deny an application for registration when an applicant has been excluded from Medicare, Medicaid, or all federal health care programs under 42 U.S.C. 1320a-7(a). In this case, HHS/OIG mandatorily excluded the applicant effective September 19, 2024 for a period of 11 years, and the DEA relied on that exclusion as a statutory basis to deny the registration.
Default for No Hearing Request
If an applicant does not file a written request for a hearing in response to an Order to Show Cause, the applicant is deemed in default and is treated as admitting the factual allegations, which can lead to a final denial. The record shows the applicant did not request a hearing and was therefore deemed in default, leading to denial.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13705 — Importer of Controlled Substances Application: Benuvia Operations, LLC.
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
2026-13581 — Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put three substances related to 7-hydroxymitragynine—Mitragynine Pseudoindoxyl, MGM-15, and MGM-16—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move aims to control these substances quickly while the DEA studies them further, affecting businesses and researchers handling these compounds.
2026-13580 — Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put 7-hydroxymitragynine above a certain amount into Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just has this substance, bringing strict rules and penalties. The move aims to keep people safe while the government figures out the long-term plan.
2026-13364 — Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.
Previous / Next Documents
Previous: 2026-00622 — Proviso Railroad, Inc.-Acquisition Exemption-L. Neill Cartage Co., Inc.
Proviso Railroad, Inc. is set to take over and operate a short rail line owned by L. Neill Cartage Co. in Berkeley, Illinois, used for moving goods like paper and lumber. This change kicks in on January 29, 2026, with no big money shifts expected since Proviso’s revenue stays small. The move keeps future rail connections open and promises smooth cargo swaps with Union Pacific Railroad.
Next: 2026-00624 — Mason Railroad, Inc.-Acquisition Exemption-L. Neill Cartage Co., Inc.
Mason Railroad, Inc. is set to take over and operate a short rail line owned by L. Neill Cartage Co. in Bedford Park, Illinois, starting January 29, 2026. This line helps move bulk goods like paper and lumber by connecting with a bigger railway. The deal won’t change future rail connections and won’t bring big money changes, keeping things smooth and local.